Geode Capital Management, LLC Dia Medica Therapeutics Inc. Transaction History

Geode Capital Management, LLC

  • $1.39 Trillion
  • Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 630,148 shares of DMAC stock, worth $3.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
630,148
Previous 315,741 99.58%
Holding current value
$3.29 Million
Previous $1.2 Million 105.43%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025
BUY
$3.38 - $4.64 $1.06 Million - $1.46 Million
314,407 Added 99.58%
630,148 $2.46 Million
Q1 2025

May 13, 2025
BUY
$3.79 - $6.65 $37,862 - $66,433
9,990 Added 3.27%
315,741 $1.2 Million
Q4 2024

Feb 12, 2025
SELL
$4.01 - $5.45 $4,840 - $6,578
-1,207 Reduced 0.39%
305,751 $1.62 Million
Q3 2024

Nov 12, 2024
BUY
$2.8 - $4.49 $196,196 - $314,614
70,070 Added 29.58%
306,958 $1.29 Million
Q2 2024

Aug 09, 2024
SELL
$2.16 - $3.66 $5,069 - $8,590
-2,347 Reduced 0.98%
236,888 $698,000
Q1 2024

May 13, 2024
BUY
$2.58 - $3.23 $52,779 - $66,076
20,457 Added 9.35%
239,235 $662,000
Q3 2023

Nov 13, 2023
BUY
$2.56 - $4.4 $86,804 - $149,195
33,908 Added 18.34%
218,778 $564,000
Q4 2022

Feb 13, 2023
SELL
$1.13 - $1.62 $394 - $565
-349 Reduced 0.19%
184,870 $292,000
Q3 2022

Nov 14, 2022
BUY
$1.2 - $2.07 $9,836 - $16,967
8,197 Added 4.63%
185,219 $229,000
Q2 2022

Aug 12, 2022
BUY
$1.86 - $2.62 $4,025 - $5,669
2,164 Added 1.24%
177,022 $357,000
Q1 2022

May 13, 2022
BUY
$2.29 - $3.88 $16,247 - $27,528
7,095 Added 4.23%
174,858 $437,000
Q3 2021

Nov 12, 2021
BUY
$3.1 - $4.32 $106,001 - $147,718
34,194 Added 25.6%
167,763 $672,000
Q2 2021

Aug 13, 2021
BUY
$4.45 - $9.91 $22,699 - $50,550
5,101 Added 3.97%
133,569 $594,000
Q1 2021

May 12, 2021
BUY
$7.76 - $10.43 $192,207 - $258,340
24,769 Added 23.89%
128,468 $1.18 Million
Q4 2020

Feb 12, 2021
BUY
$4.13 - $10.14 $169,482 - $416,115
41,037 Added 65.49%
103,699 $1.05 Million
Q3 2020

Nov 13, 2020
BUY
$3.91 - $7.15 $24,437 - $44,687
6,250 Added 11.08%
62,662 $265,000
Q2 2020

Aug 13, 2020
SELL
$2.6 - $7.32 $2,891 - $8,139
-1,112 Reduced 1.93%
56,412 $390,000
Q1 2020

May 14, 2020
BUY
$2.25 - $5.64 $89,925 - $225,413
39,967 Added 227.64%
57,524 $161,000
Q4 2019

Feb 13, 2020
BUY
$1.8 - $5.04 $3,884 - $10,876
2,158 Added 14.01%
17,557 $85,000
Q3 2019

Nov 12, 2019
BUY
$2.07 - $4.88 $31,875 - $75,147
15,399 New
15,399 $31,000

Others Institutions Holding DMAC

# of Institutions
58
Shares Held
5.97M
Call Options Held
14.1K
Put Options Held
0
View Full List

About DiaMedica Therapeutics Inc.

DMAC Quotes by TradingView
  • Ticker DMAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,443,100
  • Market Cap $138M
  • Description
  • DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...
More about DMAC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email